Lion Point Capital, LP
Lion Point Capital, LP reported 34 holdings worth US$17.3M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Lion Point Capital, LP reported 34 holdings worth US$17.3M as of Sep 30, 2026. Largest: Cue Biopharma, Inc., Praxis Precision Medicines, Inc. and Fennec Pharmaceuticals Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 34
- Value as reported
- US$17.3M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Cue Biopharma, Inc. | 52,928 | US$1.37M | 7.9% |
| Praxis Precision Medicines, Inc. | 4,450 | US$1.3M | 7.5% |
| Fennec Pharmaceuticals Inc. | 112K | US$1.2M | 6.9% |
| COMPASS Pathways Plc | 80,000 | US$995K | 5.8% |
| Geron Corporation | 578K | US$711K | 4.1% |
| Milestone Pharmaceuticals Inc. | 820K | US$710K | 4.1% |
| Biohaven Ltd. | 51,700 | US$690K | 4.0% |
| Syndax Pharmaceuticals, Inc. | 36,000 | US$677K | 3.9% |
| Benitec Biopharma Inc. | 62,000 | US$620K | 3.6% |
| Disc Medicine, Inc. | 8,100 | US$530K | 3.1% |
| Sarepta Therapeutics, Inc. | 28,500 | US$519K | 3.0% |
| Kura Oncology, Inc. | 46,000 | US$493K | 2.9% |
| Viatris Inc. | 27,700 | US$491K | 2.8% |
| Ardelyx, Inc. | 129K | US$440K | 2.5% |
| Edgewise Therapeutics, Inc. | 9,100 | US$369K | 2.1% |
| Azenta, Inc. | 9,700 | US$338K | 2.0% |
| Pacira BioSciences, Inc. | 13,500 | US$338K | 2.0% |
| Humacyte, Inc. | 650K | US$337K | 1.9% |
| BridgeBio Pharma, Inc. | 5,000 | US$329K | 1.9% |
| Janux Therapeutics, Inc. | 19,000 | US$328K | 1.9% |
| Dyne Therapeutics, Inc. | 18,000 | US$290K | 1.7% |
| Jasper Therapeutics, Inc. | 465K | US$270K | 1.6% |
| Mineralys Therapeutics, Inc. | 10,500 | US$264K | 1.5% |
| Rocket Pharmaceuticals, Inc. | 86,000 | US$226K | 1.3% |
| Regenxbio Inc. | 26,600 | US$200K | 1.2% |
| Innoviva, Inc. | 8,200 | US$174K | 1.0% |
| Arcutis Biotherapeutics, Inc. | 5,250 | US$139K | 0.80% |
| Innate Pharma SA Class A | 81,151 | US$132K | 0.77% |
| Seres Therapeutics, Inc. | 31,570 | US$106K | 0.61% |
| Spruce Biosciences, Inc. | 1,000 | US$48,580 | 0.28% |
| Lantheus Holdings, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related